Cambridge Cancer Genomics YC Application

Summer 2017Inactive

Cambridge Cancer Genomics went through Y Combinator in the Summer 2017 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Summer 2017
Industry: HealthcareDiagnostics
Team size: 25
Status: Inactive
Launched: 2017

Founders

John CassidyFounder/CEO
Nirmesh PatelFounder/Chief Scientific Officer
Evaline TsaiFounder/CPO

What Cambridge Cancer Genomics does

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to

Cambridge Cancer Genomics's YC application, reconstructed

Y Combinator application

Cambridge Cancer Genomics, Summer 2017 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Cambridge Cancer Genomics

Describe what your company does in 50 characters or less.

Personalized cancer treatment planning software

What is your company going to make? Please describe your product and what it does or will do.

We build software that helps oncologists interpret clinical and genomic data to pick the right drug for each cancer patient. Our platform analyzes patient biomarkers and treatment responses to guide precision oncology decisions.

Where do you live now, and where would the company be based after YC?

We currently live and work in Cambridge, England, United Kingdom, and the company remains based there.

Explain your decision regarding location.

Cambridge has the scientific and clinical expertise in genomics and oncology we need. Being close to hospitals and research centers allows faster collaboration and product validation.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Cambridge Cancer Genomics YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Cambridge Cancer Genomics's public data (launch notes, founder backgrounds, product description). It shows how a company like Cambridge Cancer Genomics would present itself to YC, not the text they submitted.

What YC batch was Cambridge Cancer Genomics in?

Cambridge Cancer Genomics was part of the Y Combinator Summer 2017 batch.

Who founded Cambridge Cancer Genomics?

Cambridge Cancer Genomics was founded by John Cassidy, Nirmesh Patel, Evaline Tsai.

What does Cambridge Cancer Genomics do?

CCG.ai empowers clinicians to make personalised treatment strategies…

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of Cambridge Cancer Genomics's application, and every other YC batch, is in YC Insights.